FrancophonIA/ELRC3.0 huggingface dataset:
English: Glycine Water for injections
Slovenian: Glicin Voda za injekcije
English: In these studies, a total of 83 subjects at least 2 years of age were treated with doses of 300 to 600 mg/kg body weight every 21 to 28 days for 6 to 12 months.
Slovenian: V teh študijah so skupaj 83 preiskovancev, starih najmanj 2 leti, zdravili z odmerki od 300 do 600 mg/kg TM vsakih 21 do 28 dni 6 do 12 mesecev.
English: This also applies to any unknown or emerging viruses or other types of infections.
Slovenian: To velja tudi za doslej še neznane ali porajajoče se viruse in druge vrste okužb.
English: E. SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION/THE MARKETING AUTHORISATION UNDER EXCEPTIONAL CIRCUMSTANCES
Slovenian: E. SPECIFIČNE ZAHTEVE ZA IZPOLNITEV UKREPOV PO PRIDOBITVI POGOJNEGA DOVOLJENJA ZA PROMET Z ZDRAVILOM / DOVOLJENJA ZA PROMET Z ZDRAVILOM V IZJEMNIH OKOLIŠČINAH
English: • Kawasaki disease (in conjunction with acetylsalicylic acid; see 4.2).
Slovenian: • Kawasakijev sindrom (v povezavi z acetilsalicilno kislino; glejte 4.2).
English: AUC0-21d (g·h/dl) (area under the curve)
Slovenian: AUC0-21d (g·h/dl) (površina pod krivuljo)
English: This half-life may vary from patient to patient, in particular in primary immunodeficiency.
Slovenian: Ta razpolovna doba pa se lahko razlikuje med bolniki, zlasti pri primarni imunski pomanjkljivosti.
English: In replacement therapy the dose may need to be individualised for each patient dependent on the pharmacokinetic and clinical response.
Slovenian: Pri nadomestnem zdravljenju boste morda morali odmerek prilagoditi vsakemu bolniku na podlagi farmakokinetičnega in kliničnega odziva.
English: Since clinical experience provides no evidence for carcinogenic potential of immunoglobulins, no experimental studies in heterogeneous species were performed.
Slovenian: Ker klinične izkušnje niso dale dokazov o kancerogenosti imunoglobulinov, eksperimentalne študije na heterolognih živalskih vrstah niso bile opravljene.
English: • Your doctor will also take special care if you have or had previously problems with your kidneys, or if you receive medicinal products that may harm your kidney (nephrotoxic medicinal products), as there is a very rare chance of acute kidney failure.
Slovenian: • Vaš zdravnik bo tudi posebej pozoren, če imate ali ste kdaj prej imeli težave z ledvicami ali če prejemate zdravila, ki lahko škodujejo vašim ledvicam (nefrotoksična zdravila), saj obstaja zelo majhna možnost akutne odpovedi ledvic.
English: There are two alternative treatment schedules:
Slovenian: Možni sta dve shemi zdravljenja:
English: Other medicines and KIOVIG
Slovenian: Druga zdravila in zdravilo KIOVIG
English: The dosing and intervals may have to be adapted according to the individual course of the disease.
Slovenian: Odmerjanje in presledke je morda treba prilagoditi glede na potek bolezni pri posamezniku.
English: Treatment of patients who do not have sufficient antibodies (replacement therapy).
Slovenian: Zdravljenje bolnikov, ki nimajo dovolj protiteles (nadomestna terapija).
English: Pharmacokinetic parameters for the product are summarized in the table below.
Slovenian: Farmakokinetični parametri zdravila so povzeti v spodnji preglednici.
English: Paediatric patients may be more susceptible to volume overload (see Section 4.9).
Slovenian: Pediatrični bolniki so lahko dovzetnejši za volumsko preobremenitev (glejte poglavje 4.9).
English: • with undetectable IgA who have anti-IgA antibodies
Slovenian: • z nezaznavnimi IgA, ki imajo protitelesa proti IgA
English: Certain adverse reactions may occur more frequently
Slovenian: Določeni neželeni učinki so lahko pogostejši:
English: All other patients should be observed for at least 20 minutes after administration.
Slovenian: Vse druge bolnike pa spremljajte še najmanj 20 minut po prejemu infuzije.
English: How long monitoring is required during the infusion
Slovenian: Kako dolgo naj traja spremljanje bolnika med infuzijo
English: TRALI is a potentially lifethreatening condition requiring immediate intensive-care-unit management.
Slovenian: TRALI je potencialno smrtno nevarno stanje, ki zahteva takojšnje zdravljenje v enoti intenzivne nege.
English: • in patients with an untreated infection or underlying chronic inflammation.
Slovenian: • pri bolnikih z nezdravljeno okužbo ali osnovnim kroničnim vnetjem.
English: Table 1 Frequency of Adverse Reactions (ADRs) in clinical studies with KIOVIG MedDRA System Organ Class (SOC)
Slovenian: Preglednica 1 Pogostnost neželenih učinkov zdravil (ADR) - klinične študije z zdravilom KIOVIG Razvrstitev organov po sistemu MedDRA (SOC)
English: 10, 25, 50, 100, 200 or 300 ml of solution in a vial (Type I glass) with a stopper (bromobutyl).
Slovenian: 10, 25, 50, 100, 200 ali 300 ml raztopine v vialah (iz stekla tipa I) z zamaškom (bromobutilnim).
English: Medicines like KIOVIG are used in patients who do not have enough antibodies in their blood and tend to get frequent infections.
Slovenian: Zdravila, kakršno je zdravilo KIOVIG, se uporabljajo za bolnike, ki v svoji krvi nimajo dovolj protiteles in pogosto zbolijo za okužbami.
English: Overdose may lead to fluid overload and hyperviscosity, particularly in patients at risk, including elderly patients or patients with cardiac or renal impairment (see section 4.4 ).
Slovenian: Preveliko odmerjanje lahko povzroči preobremenitev s tekočinami in hiperviskoznost, zlasti pri ogroženih bolnikih (med drugim pri starostnikih ali pri bolnikih s srčno ali ledvično okvaro) (glejte poglavje 4.4).
English: After infusion of immunoglobulin the transitory rise of the various passively transferred antibodies in the patient's blood may result in misleading positive results in serological testing.
Slovenian: Po infuziji imunoglobulinov lahko prehodno zvišanje različnih pasivno prenesenih protiteles v bolnikovi krvi povzroči lažno pozitivne rezultate seroloških preiskav.
English: Patients who experience adverse reactions during treatment should wait for these to resolve before driving or operating machines.
Slovenian: Bolniki, pri katerih se med zdravljenjem pojavijo neželeni učinki, morajo počakati, da ti izzvenijo, preden lahko vozijo ali upravljajo s stroji.
English: Summary of KIOVIG pharmacokinetic parameters
Slovenian: Povzetek farmakokinetičnih parametrov zdravila KIOVIG
English: Maintenance doses:
Slovenian: Vzdrževalni odmerki:
English: Patients may experience reactions (for example dizziness or nausea) during the treatment with KIOVIG, which might affect the ability to drive and use machines.
Slovenian: Pri bolnikih se lahko med zdravljenjem z zdravilom KIOVIG pojavijo reakcije (npr. omotica in slabost), kar lahko vpliva na sposobnost vožnje in upravljanja s stroji.
English: The dose recommendations are summarised in the following table:
Slovenian: Priporočila za odmerjanje so povzeta v naslednji preglednici:
English: Solutions that are cloudy or have deposits should not be used.
Slovenian: Raztopin, ki so motne ali vsebujejo usedline, ne smete uporabiti.
English: MedDRA System Organ Class (SOC)
Slovenian: Razvrstitev organov po sistemu MedDRA (SOC)
English: 3, predominantly from the granulocytic series, and elevated protein levels up to several hundred mg/dL. AMS may occur more frequently in association with high-dose (2 g/kg) IVIg treatment.
Slovenian: 3, zlasti iz granulocitne linije, in zvišanimi koncentracijami beljakovin do več sto mg/dl. AMS se lahko pojavi pogosteje v povezavi z velikimi odmerki (2 g/kg) i.v.
English: No dose adjustment unless clinically warranted, see section 4.4.
Slovenian: Odmerka se ne prilagaja, razen če je klinično potrebno; glejte poglavje 4.4.
English: The dose and dose regimen is dependent on the indication.
Slovenian: Odmerek in shema odmerjanja sta odvisna od indikacije.
English: Hypersensitivity to human immunoglobulins, especially in patients with antibodies against IgA.
Slovenian: Preobčutljivost za človeške imunoglobuline, zlasti pri bolnikih s protitelesi proti IgA.
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu
English: In the case of measles, this impairment may persist for up to 1 year.
Slovenian: V primeru ošpic lahko opisano zmanjšanje učinkovitosti traja celo do enega leta.
English: The tables presented below are according to the MedDRA system organ classification (SOC and Preferred Term Level).
Slovenian: Spodnji preglednici temeljita na razvrstitvi organov po sistemu MedDRA (SOC in najprimernejši izrazi).
English: Pack size: 1 vial
Slovenian: Velikosti pakiranj: 1 viala.
English: KIOVIG belongs to a class of medications called immunoglobulins.
Slovenian: Zdravilo KIOVIG sodi v skupino zdravil, ki jih imenujemo imunoglobulini.
English: In rare cases your body may have previously reacted to specific antibodies and therefore will be sensitive to medicines containing antibodies.
Slovenian: Redko se lahko zgodi, da je vaše telo v preteklosti reagiralo na specifična protitelesa, zato ste preobčutljivi za zdravila, ki vsebujejo protitelesa.
English: Immunomodulation:
Slovenian: Imunomodulacija:
English: • You will be carefully observed during the infusion period with KIOVIG to make sure that you do not suffer a reaction.
Slovenian: • Med infundiranjem zdravila KIOVIG vas bodo skrbno spremljali, da zagotovijo, da ne boste imeli reakcije.
English: Dependent on how comfortable you are, your doctor may then gradually increase the infusion rate.
Slovenian: Glede na vaše počutje bo zdravnik potem lahko postopoma povečeval hitrost infundiranja.
English: • Do not store above 25°C.
Slovenian: • Shranjujte pri temperaturi do 25°C.
English: IgG and IgG-complexes are broken down in cells of the reticuloendothelial system.
Slovenian: IgG in imunske komplekse z IgG v telesu razgradijo celice retikuloendotelijskega sistema.
English: If you experience a reaction during the infusion of KIOVIG, tell your doctor immediately.
Slovenian: Če pride med infundiranjem zdravila KIOVIG do reakcije, nemudoma obvestite svojega zdravnika.
English: Although KIOVIG does not contain sugar, it may be diluted with a special sugar solution (5% glucose), which could affect your blood sugar level.
Slovenian: Čeprav zdravilo KIOVIG ne vsebuje sladkorja, ga lahko redčijo s posebno raztopino sladkorja (5 % glukoze), kar bi lahko vplivalo na koncentracijo sladkorja v vaši krvi.
English: The dose regimen should achieve a trough level of IgG (measured before the next infusion) of at least 5 to 6 g/L.
Slovenian: S shemo odmerjanja morate doseči najnižjo koncentracijo IgG (izmerjeno pred naslednjo infuzijo) najmanj 5 do 6 g/l.
English: Patients who suffer from a rare condition characterized by slow progressive asymmetrical weakness of limbs without sensory loss (multifocal motor neuropathy, MMN).
Slovenian: Bolniki z redko boleznijo, za katero je značilna počasi napredujoča asimetrična oslabelost udov brez čutilne izgube (multifokalno motorično nevropatijo, MNN).
English: Immunoglobulins are normal constituents of the human body.
Slovenian: Imunoglobulini so običajne sestavine človeškega telesa.
English: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products, nor with any other IVIg products.
Slovenian: Zaradi pomanjkanja študij kompatibilnosti zdravila ne smemo mešati z drugimi zdravili ali z drugimi pripravki i.v.
English: • Guillain Barré syndrome.
Slovenian: • Guillain-Barréjev sindrom.
English: Treatment of patients with certain inflammatory disorders (immunomodulation).
Slovenian: Zdravljenje bolnikov z določenimi vnetnimi boleznimi (imunomodulacija).
English: If the treatment is effective long term treatment should be subject to the physicians discretion based upon the patient response and maintenance response.
Slovenian: Če je zdravljenje učinkovito, zdravnik presodi o dolgoročnem zdravljenju glede na bolnikov odziv in odziv na vzdrževalni odmerek.
English: *PSAF = failure to mount at least a 2-fold rise in IgG antibody titre to pneumococcal polysaccharide and polypeptide antigen vaccines
Slovenian: *PSAF = neuspešno doseganje vsaj 2-kratnega dviga titra protiteles IgG pri cepljenju s pnevmokoknimi cepivi s polisaharidnimi in polipeptidnimi antigeni.
English: Each vial of 10 ml contains: 1 g of human normal immunoglobulin Each vial of 25 ml contains: 2.5 g of human normal immunoglobulin Each vial of 50 ml contains: 5 g of human normal immunoglobulin Each vial of 100 ml contains: 10 g of human normal immunoglobulin Each vial of 200 ml contains: 20 g of human normal immunoglobulin Each vial of 300 ml contains: 30 g of human normal immunoglobulin
Slovenian: Vsaka viala z 10 ml vsebuje: 1 g humanega polispecifičnega imunoglobulina Vsaka viala s 25 ml vsebuje: 2,5 g humanega polispecifičnega imunoglobulina Vsaka viala s 50 ml vsebuje: 5 g humanega polispecifičnega imunoglobulina Vsaka viala s 100 ml vsebuje: 10 g humanega polispecifičnega imunoglobulina Vsaka viala z 200 ml vsebuje: 20 g humanega polispecifičnega imunoglobulina Vsaka viala s 300 ml vsebuje: 30 g humanega polispecifičnega imunoglobulina
English: Manufacturers of these products also include steps in the processing of the blood or plasma that can inactivate or remove viruses.
Slovenian: Izdelovalci teh zdravil v proces obdelave krvi ali plazme dodajo tudi različne postopke, s katerimi lahko inaktivirajo ali odstranijo viruse.
English: Potential complications can often be avoided by ensuring that patients: - are not sensitive to human normal immunoglobulin by initially injecting the product slowly (0.5 ml/kg BW/hr); - are carefully monitored for any symptoms throughout the infusion period.
Slovenian: Možnim zapletom se lahko pogosto izognete tako, da zagotovite: - da bolniki niso preobčutljivi za humani polispecifični imunoglobulin, in sicer tako, da zdravilo najprej injicirate počasi (0,5 ml/kg TM/uro); - skrbno spremljanje bolnikov ves čas trajanja infuzije, da bi ugotovili morebitne simptome.
English: Maximum immunoglobulin A (IgA) content: 140 micrograms/ml.
Slovenian: Največja vsebnost imunoglobulina A (IgA): 140 mikrogramov/ml.
English: Coombs direct test positive, oxygen saturation decreased
Slovenian: Preiskave pozitiven direktni Coombsov test, zmanjšana saturacija krvi s kisikom neznani
English: The ability to drive and operate machines may be impaired by some adverse reactions associated with KIOVIG.
Slovenian: Sposobnost vožnje in upravljanja s stroji je lahko zaradi nekaterih neželenih učinkov zdravila KIOVIG zmanjšana.
English: In most cases, risk factors have been identified, such as pre-existing renal insufficiency, diabetes mellitus, hypovolaemia, overweight, concomitant nephrotoxic medicinal products, age over 65, sepsis, hyperviscosity or paraproteinemia.
Slovenian: V večini primerov so ugotovili dejavnike tveganja, kot so obstoječa ledvična insuficienca, sladkorna bolezen, hipovolemija, čezmerna telesna masa, sočasna uporaba nefrotoksičnih zdravil, starost nad 65 let, sepsa, hiperviskoznost in paraproteinemija.
English: Studies of repeated dose toxicity, genotoxicity, and toxicity to reproduction in animals are impracticable due to induction of and interference by developing antibodies to heterologous proteins.
Slovenian: Študije toksičnosti pri ponavljajočih se odmerkih, genotoksičnosti in vpliva na sposobnost razmnoževanja pri živalih niso izvedljive zaradi spodbujanja nastanka protiteles proti heterolognim beljakovinam in motenj, ki jih povzročajo ta protitelesa.
English: • No clinical trials have been made with KIOVIG in pregnant or breast-feeding women.
Slovenian: • Ni bilo kliničnih preskušanj z zdravilom KIOVIG pri nosečnicah ali doječih materah.
English: These include careful selection of blood and plasma donors to make sure those at risk of carrying infections are excluded, and the testing of each donation and pools of plasma for signs of virus/infections.
Slovenian: Sem sodijo skrbna izbira darovalcev krvi in plazme, pri čemer izključimo osebe s tveganjem za prenos okužbe, in hkratno preiskovanje vsake darovane enote krvi ali plazme in združene plazme na pokazatelje virusov oz. okužb.
English: At the beginning of your infusion you will receive KIOVIG at a slow rate.
Slovenian: Sprva boste infuzijo zdravila KIOVIG prejemali počasi.
English: There are no theoretical or observed differences in the action of immunoglobulins in children compared to adults.
Slovenian: Med odraslimi in otroki ni niti teoretičnih niti opaženih razlik v delovanju imunoglobulinov.
English: • Your doctor will take special care if you are overweight, elderly, diabetic, or if you suffer from high blood pressure, low blood volume (hypovolaemia), or problems with your blood vessels (vascular diseases).
Slovenian: • Vaš zdravnik bo posebno previden, če imate čezmerno telesno maso, če ste starejši ali če imate sladkorno bolezen, visok krvni tlak, zmanjšan volumen krvi (hipovolemijo) ali težave z ožiljem (žilne bolezni).
English: In these conditions, immunoglobulins may increase the risk of cardiac infarction, stroke, lung embolism, or deep vein thrombosis, although only in very rare cases.
Slovenian: V teh primerih lahko imunoglobulini povečajo tveganje za srčni infarkt, možgansko kap, pljučno embolijo ali globoko vensko trombozo, čeprav le v zelo redkih primerih.
English: Increase in serum creatinine level and/or acute renal failure have been observed.
Slovenian: Opažali so tudi povečanje serumske koncentracije kreatinina in/ali akutno ledvično odpoved.
English: The following dose regimens are given as a guideline.
Slovenian: Naslednje sheme odmerjanja so navedene kot smernice:
English: Interference with serological testing
Slovenian: Napake pri seroloških preiskavah
English: Patients with a disease that is associated with multiple inflammations of the nerves in the whole body (Guillain Barré syndrome).
Slovenian: Bolniki z boleznijo, ki je povezana z vnetjem živcev na več mestih po vsem telesu (Guillain-Barréjev sindrom).
English: Hypogammaglobulinaemia (<4 g/l) in patients after allogeneic haematopoietic stem cell transplantation
Slovenian: Hipogamaglobulinemija(<4 g/l) pri bolnikih po alogenski presaditvi krvotvornih matičnih celic
English: This could particularly happen when you are a patient at risk, e.g. an elderly patient or a patient having problems with your kidneys.
Slovenian: To se lahko zgodi zlasti, če sodite v skupino rizičnih bolnikov (npr. starostniki ali bolniki, ki imajo težave z ledvicami).
English: IgG trough levels should be measured and assessed in conjunction with the incidence of infection.
Slovenian: Izmeriti morate najnižje koncentracije IgG in jih ovrednotiti v povezavi s pojavnostjo okužb.
English: The treatment can be repeated if relapse occurs.
Slovenian: V primeru relapsa lahko zdravljenje ponovite.
English: Please tell your doctor if you have a kidney disorder.
Slovenian: Povejte zdravniku, če imate ledvično bolezen.
English: Pharmacotherapeutic group: immune sera and immunoglobulins: immunoglobulins, normal human, for intravascular administration, ATC code: J06BA02
Slovenian: Farmakoterapevtska skupina: imunski serumi in imunoglobulini: humani imunoglobulini za intravaskularno aplikacijo, oznaka ATC: J06BA02
English: Human normal immunoglobulin ……………100 mg (purity of at least 98% IgG)
Slovenian: Humani polispecifični imunoglobulin ……………100 mg (čistost najmanj 98 % IgG)
English: Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents.
Slovenian: Humani polispecifični imunoglobulin vsebuje predvsem imunoglobulin G (IgG) s široko paleto protiteles proti povzročiteljem nalezljivih bolezni.
English: Administration of KIOVIG can lead to false positive readings in assays that depend on detection of beta-D-glucans for diagnosis of fungal infections.
Slovenian: Uporaba zdravila KIOVIG lahko povzroči lažno pozitivne rezultate testov, ki temeljijo na zaznavanju beta-D-glukanov za diagnostiko glivnih okužb.
English: • monitoring of serum creatinine levels
Slovenian: • spremljanje serumske koncentracije kreatinina
English: 0.8-1 g/kg or
Slovenian: 0,8-1 g/kg ali
English: Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses.
Slovenian: Standardni ukrepi za preprečevanje okužb zaradi uporabe zdravil, pripravljenih iz človeške krvi ali plazme, so med drugim: selekcija darovalcev, presejalno testiranje posameznih enot darovane krvi in združene plazme na specifične markerje okužbe ter vključitev učinkovitih postopkov za inaktivacijo oz. odstranitev virusov pri izdelavi zdravila.
English: Patients who do not have enough blood platelets (primary immune thrombocytopenia, ITP), and who are at high risk of bleeding or will have surgery in the near future.
Slovenian: Bolniki, ki nimajo dovolj trombocitov v krvi (primarna imunska trombocitopenija) in imajo veliko tveganje za krvavitve ali bodo kmalu operirani.
English: KIOVIG also contains certain antibodies that can prevent an infection with hepatitis A virus and parvovirus B19.
Slovenian: Zdravilo KIOVIG vsebuje tudi določena protitelesa, ki lahko preprečijo okužbo z virusom hepatitisa A in parvovirusom B19.
English: • Do not use this medicine if you notice particulate matter or discolouration.
Slovenian: • Ne uporabljajte tega zdravila, če opazite v njem delce ali če je raztopina obarvana.
English: Clinical experience with immunoglobulins suggests that no harmful effects on fertility are to be expected.
Slovenian: Klinične izkušnje z imunoglobulini kažejo, da škodljivih učinkov na plodnost ne pričakujemo.
English: Certain side effects, e.g. headache or flushing, may be reduced by slowing the infusion rate.
Slovenian: Določene neželene učinke, npr. glavobol ali pordelost, je mogoče zmanjšati z zmanjšanjem hitrosti infundiranja.
English: Therefore, after receiving immunoglobulins you may have to wait up to 3 months before receiving your live-attenuated vaccine.
Slovenian: Zato boste morda morali po prejemu teh imunoglobulinov počakati do 3 mesece, preden lahko prejmete živo oslabljeno cepivo.
English: For instructions on dilution of the medicinal product before administration, see section 6.6.
Slovenian: Za navodila glede raztapljanja zdravila pred dajanjem glejte poglavje 6.6.
English: • who had tolerated previous treatment with human normal immunoglobulin
Slovenian: • ki so dobro prenašali predhodno zdravljenje s humanim polispecifičnim imunoglobulinom
English: The safety of this medicinal product for use in human pregnancy has not been established in controlled clinical trials and therefore it should only be given with caution to pregnant women and breast-feeding mothers.
Slovenian: Varnosti zdravila v času nosečnosti pri človeku še niso ugotavljali v nadzorovanih kliničnih raziskavah in ga morate zato v času nosečnosti in dojenja uporabljati previdno.
English: 1 g/kg over 1-2 consecutive days every 3 weeks.
Slovenian: 1 g/kg v obdobju 1-2 zaporednih dni vsake 3 tedne.
English: If you have received a vaccination during the last six weeks and up to three months, the infusion of immunoglobulins like KIOVIG may impair the effect of some live virus vaccines such as measles, rubella, mumps and chicken pox.
Slovenian: Če ste bili cepljeni v zadnjih šestih tednih oz. treh mesecih, lahko infuzija imunoglobulinov, kot je zdravilo KIOVIG, zmanjša učinkovitost nekaterih živih virusnih cepiv, kot so cepiva proti ošpicam, rdečkam, mumpsu in noricam.
English: 121 87 to 137 99 75 to 121 104 96 to 114
Slovenian: 121 87 do 137 99 75 do 121 104 96 do 114